Staying true to its mission of helping Taiwanese startups pursue cross-border collaborations and global expansion, i2i teamed up with the Canadian Technology Accelerator (CTA) on October 24 to co-host an International Demo Day. The event brought together six international startups that showcased their innovative technologies and solutions.
Following the event, i2i introduced Canadian MedTech startup PragmaClin Research to corporate resources in Taiwan.
On December 6, i2i invited Michael Kuo, CEO of HukuiBio and member of the international Review Board, to meet with PragmaClin Research Founder and CEO, Bronwyn Bridges. They exchanged ideas on advancing innovation in long-term care and discussed ways to explore the potential of Taiwan’s market through global partnerships.
HukuiBio (HukuiBio) is a leading Taiwanese MedTech company that has long focused on remote healthcare and AI-powered medical devices.
With a growing international presence, the company offers cutting-edge medical technology and clinical solutions across Asia.
PragmaClin Research, on the other hand, has garnered professional testing results in senior healthcare and home care in Canada.
The company has begun small-scale commercialization in North America and now aims to establish a foothold in Asia.
During the meeting, both parties explored methods to adapt PragmaClin’s existing long-term care devices and technologies for the Taiwanese market, including customizing solutions for the Asia-Pacific region.
HukuiBio also offered advice on product regulations, clinical trial processes, and commercial partnership models.
As an ecosystem connector, i2i draws on extensive collaboration with businesses, government, and academia to link startups with expert advisors and market resources.
For international startups, i2i provides the localized industry, policy, and regulatory support they need to succeed.
As Taiwan moves closer to becoming a super-aged society, demand for long-term care and healthcare solutions will keep rising.
Combining the research and development strengths of international startups with the in-depth market knowledge of local companies can lead to more valuable products and services—ultimately offering a forward-thinking and people-focused approach for the future of healthcare.
Comments